Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HDL-Based Pharmaceutical Products
Sort By
Newest First
1 / 1
1 / 1
Strategic Initiative
CERENIS Therapeutics and University of North Texas Health Science Center Announce a Strategic Initiative to Develop New HDL-Based Pharmaceutical Products
ABIONYX Pharma
PR-M05-18-NI-117
May 31, 2018
